Hospital Ruber Internacional;Servicio de Oncologia

Madrid 28034

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Triple Negative Breast Neoplasms

Studies at this site

• Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer — Stopped early
• A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer — Completed